✦ LIBER ✦

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

✍ Scribed by O.W Press; F Appelbaum; P.J Martin; D.C Matthews; I.D Bernstein; J.F Eary; W.B Nelp; T Gooley; S Glenn; B Porter; D.R Fisher

Book ID: 118559247
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 699 KB
Volume: 346
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)92225-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of 131-Iodine Tositumomab

Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma

✍ Vose, Julie M.; Bierman, Philip J.; Loberiza, Fausto R.; Enke, Charles; Hankins, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Phase I Clinical Trial Targeting CD20+ N

Phase I Clinical Trial Targeting CD20+ Non-Hodgkin'S Lymphoma (NHL) After Autologous Stem Cell Transplant With Anti-CD3 × Anti-CD20 Bispecific Antibody Armed T Cells

✍ L.G. Lum; A. Thakur; V. Ratanatharathorn; Z. Al-Kadhimi; E. Paul; C. Skuba; P. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Rituximab Maintenance Therapy After Auto

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

✍ Gisselbrecht, C.; Schmitz, N.; Mounier, N.; Singh Gill, D.; Linch, D. C.; Trneny 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 218 KB

Tandem high-dose therapy in relapsed and

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with131I-anti-CD20 antibody and stem cell rescue

✍ Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 233 KB

Systemic therapy with cyclophosphamide a

Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases

✍ Maria T Fierro; Paola Savoia; Pietro Quaglino; Mauro Novelli; Manuela Barberis; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 356 KB